Skip to content

Study · Not a test of the peptide alone · 1993

1 result

[The effect of cytostatic and immunomodulator therapy on the morphology of the tumor and lymphoid organs and on the count of large granular lymphocytes in the blood of mice with Lewis carcinoma].

Potapov IuI, Khaleev DV, Krutova TV, Pashkova VS

Izvestiia Akademii nauk. Seriia biologicheskaia1 Jan 1993

PMID8471967 (opens in a new tab)PepBankPUB-08471967
Publisher pageAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymalin.

  1. 01AnimalNot a test of Thymalin aloneAnimal study (in vivo)Efficacy outcome

    In mice with Lewis lung carcinoma, pooled immunomodulators including thymalin only slightly reversed immune suppression associated with NMU treatment.

    In plain wordsIn mice with Lewis lung carcinoma, pooled immunomodulators including thymalin only slightly reversed immune suppression from NMU.

    Peptide
    Thymalin
    Outcome
    DecreaseHost immune suppression
    Study

    mousen: not reported in source

    Lewis lung carcinoma
    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    The direct NMU damage to tumor was accompanied by a suppression of host immune system which was only slightly reversed with immunomodulators.
    1 context sentence
    Summary · context
    Effects of separate and combined therapy with nitrosomethylurea (NMU), methotrexate thymalin, and reaferon on tumor, thymus and spleen morphology as well as the content of large granular lymphocytes in blood were studied in mice with Lewis lung carcinoma.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.